HOUSE RX, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	2
2025	—	7	2
2024	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MARSHALL & POPP, LLC	—	10
AVENUE SOLUTIONS	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	6
HOUSE OF REPRESENTATIVES	5

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	8
Health Issues	Health Issues	6

Bills Explicitly Cited (22)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · fourth_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025

Client expense: — · Firm income: $50,000

Matched citations: H.R.2484

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · fourth_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025

Client expense: — · Firm income: $50,000

Matched citations: H.R.2484

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act.

Client expense: — · Firm income: $30,000

Matched citations: H.R.2484

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · third_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025

Client expense: — · Firm income: $10,000

Matched citations: H.R.2484

Show 18 more cited filings

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · third_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025

Client expense: — · Firm income: $10,000

Matched citations: H.R.2484

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act.

Client expense: — · Firm income: —

Matched citations: H.R.2484

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · third_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025

Client expense: — · Firm income: —

Matched citations: H.R.2484

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2025 · third_quarter · Firm: AVENUE SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.2484 - Seniors Access to Critical Medications Act of 2025

Client expense: — · Firm income: —

Matched citations: H.R.2484

H.R. 10545118th Congress

American Relief Act, 2025

2024 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023. H.R.10545, FY25 Continuing Appropriations.

Client expense: — · Firm income: $30,000

Matched citations: H.R.10545

H.R. 10545118th Congress

American Relief Act, 2025

2024 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023. H.R.10545, FY25 Continuing Appropriations.

Client expense: — · Firm income: $30,000

Matched citations: H.R.10545

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023. H.R.10545, FY25 Continuing Appropriations.

Client expense: — · Firm income: $30,000

Matched citations: H.R.5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023. H.R.10545, FY25 Continuing Appropriations.

Client expense: — · Firm income: $30,000

Matched citations: H.R.5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023. H.R.10545, FY25 Continuing Appropriations.

Client expense: — · Firm income: $30,000

Matched citations: S.3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · fourth_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023. H.R.10545, FY25 Continuing Appropriations.

Client expense: — · Firm income: $30,000

Matched citations: S.3458

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: H.R.5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: H.R.5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: S.3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: $30,000

Matched citations: S.3458

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: H.R.5526

H.R. 5526118th Congress

Seniors’ Access to Critical Medications Act of 2024

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: H.R.5526

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: S.3458

S. 3458118th Congress

Seniors’ Access to Critical Medications Act of 2023

2024 · third_quarter · Firm: MARSHALL & POPP, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R.5526/S.3458 - Seniors Access to Critical Medications Act of 2023.

Client expense: — · Firm income: —

Matched citations: S.3458

Source: Senate LDA

HOUSE RX, INC. — Lobbying Disclosure | Poliscope